Invention Grant
- Patent Title: Glucagon receptor antagonists, preparation and therapeutic uses
- Patent Title (中): 胰高血糖素受体拮抗剂，制剂和治疗用途
-
Application No.: US12093601Application Date: 2006-11-16
-
Publication No.: US08691856B2Publication Date: 2014-04-08
- Inventor: Scott Eugene Conner , Philip Arthur Hipskind , Jianke Li , Guoxin Zhu
- Applicant: Scott Eugene Conner , Philip Arthur Hipskind , Jianke Li , Guoxin Zhu
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Dan L. Wood
- International Application: PCT/US2006/060976 WO 20061116
- International Announcement: WO2007/120270 WO 20071025
- Main IPC: A01N43/64
- IPC: A01N43/64 ; A61K31/41 ; C07D257/04 ; C07D257/10 ; C07D403/00 ; C07D487/00
Abstract:
The present invention discloses novel compounds of Formula (I), or pharmaceutically acceptable salts thereof, which have glucagon receptor antagonist or inverse agonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula (I) as well as methods of using them to treat diabetic and other glucagon related metabolic disorders, and the like.
Public/Granted literature
- US20090156655A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES Public/Granted day:2009-06-18
Information query
IPC分类:
